JOINN Biologics

company

About

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.

  • 251 - 500

Details

Last Funding Type
Series A
Last Funding Money Raised
$60M
Industries
Biopharma,Biotechnology,Manufacturing
Founded date
May 1, 2018
Number Of Employee
251 - 500
Operating Status
Active

JOINN Biologics is a California Bay Area-based company that is committed to the advancement of biotech and biopharmaceutics through our premier contract manufacturing and development services for biologics and advanced therapies. A vital part of the JOINN Family's successful 20+ year track record of supporting drug discovery and development, we provide a complete range of CDMO services, from early development to clinical manufacturing, for our clients and partners on a global scale.


Core Capabilities

• Molecular/developability assessment

• cGMP clinical trial materials production

• Commercial-scale cGMP manufacturing

• Non-GMP protein expression and purification

• Cell line development

• Upstream process development

• Downstream purification development

• Analytical and formulation development

• Documentation and reporting to support regulatory filings


Mission

It is our mission to provide our global clients and partners with a complete range of premier contract development and manufacturing services for biologics and advanced therapies, from early custom development to clinical manufacturing, to further accelerate the development of high-quality biologics, meeting patients' needs and delivering long-lasting value to the biotech and biopharmaceutical industry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$60M
JOINN Biologics has raised a total of $60M in funding over 2 rounds. Their latest funding was raised on Dec 10, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 10, 2019 Series A $60M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
JOINN Biologics is funded by 2 investors. Chaosheng Capital and Suzhou Xiangtang Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Chaosheng Capital Series A
Suzhou Xiangtang Venture Capital Series A